RESUMEN
BACKGROUND: Without treatment, the natural history of central retinal vein occlusion (CRVO) can result in severe loss of vision. MATERIAL AND METHODS: This was a retrospective study of 10 eyes with CRVO treated with pars plana vitrectomy (PPV), combined with radial optic neurotomy. The patients completed a minimum of 5 years follow-up. RESULTS: Median age at the time of surgery was 67 ± 14 years. Median follow-up was 79 ± 9 months. Ischaemic changes were present in 4 patients pre-operatively. Baseline median logMAR BCVA was 2.00 ± 0.76 and improved significantly to a median of 0.35 ± 0.54 (p < 0.0001, two tailed t test) at 5 years follow-up. The baseline median central macular thickness (CMT) was 645 ± 108 µm and improved significantly, to a median of 203 ± 72 µm (p < 0.0001, two tailed t test). One of the patients developed neovascular complications during the follow-up period. CONCLUSIONS: Our results compare very favorably with the natural history of CRVO. All patients demonstrated a trend to improved visual acuity, while only one of the patients developed neovascular complications. These results provide information on the potential long-term effect of PPV in patients with CRVO and may help to reassess the place of the surgical management of CRVO in patients who do not respond to medical treatment.
Asunto(s)
Descompresión Quirúrgica/métodos , Procedimientos Neuroquirúrgicos/métodos , Nervio Óptico/cirugía , Oclusión de la Vena Retiniana/diagnóstico , Oclusión de la Vena Retiniana/cirugía , Trastornos de la Visión/prevención & control , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Oclusión de la Vena Retiniana/complicaciones , Estudios Retrospectivos , Resultado del Tratamiento , Trastornos de la Visión/etiología , Agudeza Visual , Vitrectomía/métodosAsunto(s)
Inhibidores de la Angiogénesis/uso terapéutico , Endotaponamiento/métodos , Hemorragia Retiniana/terapia , Trastornos de la Visión/prevención & control , Anciano , Terapia Combinada/métodos , Femenino , Gases/administración & dosificación , Humanos , Hemorragia Retiniana/complicaciones , Hemorragia Retiniana/diagnóstico , Resultado del Tratamiento , Factor A de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Trastornos de la Visión/diagnóstico , Trastornos de la Visión/etiología , Agudeza Visual , VitrectomíaRESUMEN
BACKGROUND: Proliferative retinopathy is an important cause of vision loss in diabetic patients. Incomplete panretinal photocoagulation (PRP) can lead to recurrent proliferation of new vessels. PATIENTS AND METHODS: We retrospectively analysed the outcome of patients with high risk proliferative diabetic retinopathy (PDR) previously treated with slit lamp PRP who underwent indirect fill in argon laser treatment with scleral indentation under anesthesia for persistent neovascular proliferation. RESULTS: Seventeen eyes of ten patients were included. The mean age at diabetes onset was 17.3 years SD 16.2 (range 2-44). All patients reported long standing poor glycemic control (mean HbA1c: 8.5% SD 1.3 range 5.9-10.2). The area of retinal ischemia decreased significantly from 15±7.5 disk areas (DA) before fill-in laser to 3.2±4.2 DA after fill-in laser (p=0.001). The new vessels also regressed significantly after laser treatment 8.6±6.1 DA before treatment versus 6.5±6.4 DA after laser treatment, (p=0.044). Quiescent PDR was reached in 10 eyes (58.8%) at the last visit. CONCLUSIONS: Fill-in indirect argon laser under general anesthesia should be considered to achieve further new vessels regression in high risk PDR patients. Scleral indentation and absence of pain may allow for more extensive laser application.
Asunto(s)
Retinopatía Diabética/cirugía , Terapia por Láser/métodos , Láseres de Gas/uso terapéutico , Fotocoagulación/métodos , Neovascularización Retiniana/cirugía , Adolescente , Adulto , Niño , Preescolar , Retinopatía Diabética/patología , Femenino , Humanos , Masculino , Neovascularización Retiniana/patología , Resultado del Tratamiento , Adulto JovenRESUMEN
BACKGROUND: The purpose of this study is to report the anatomic and functional results of primary 23 G vitrectomy using slit-lamp and non-contact 90 D lens for the treatment of pseudophakic rhegmatogenous retinal detachment. PATIENTS AND METHODS: Pseudophakic eyes were operated by 23 G vitrectomy using slit-lamp and non-contact 90 D lens, internal subretinal fluid drainage, cryopexy and internal gas tamponade. The preoperative and postoperative characteristics were analysed. Main outcome measures were anatomic success rates after initial surgical intervention and after reoperation for primary failures, visual outcome at the last follow-up visit, and complications. RESULTS: 46 pseudophakic eyes were included in this retrospective study (October 2013- January 2014). In 40 cases, sulfur hexafluoride 23% gastamponade was used, silicone oil in 6 cases (13%). The retina was reattached successfully after a single surgery in 44 eyes (96%). Recurrence of retinal detachment occurred in 2 eyes. Final anatomic reattachment was obtained in 100% after a second operation. Silicone oil was removed in all eyes. Visual acuity improved significantly from logMAR 0 (IQR 0-0.9) to logMAR 0 (IQR 0-0.2) (p<0.005). CONCLUSIONS: Primary 23 G vitrectomy using slit-lamp and non contact 90 D lens for the treatment of pseudophakic rhegmatogenous retinal detachment provides a high anatomic and functional success rate and is associated with few complications.
Asunto(s)
Lentes , Seudofaquia/cirugía , Desprendimiento de Retina/cirugía , Lámpara de Hendidura , Cirugía Asistida por Computador/instrumentación , Vitrectomía/instrumentación , Extracción de Catarata/efectos adversos , Femenino , Humanos , Aumento de la Imagen/instrumentación , Masculino , Persona de Mediana Edad , Seudofaquia/etiología , Seudofaquia/patología , Reproducibilidad de los Resultados , Desprendimiento de Retina/etiología , Desprendimiento de Retina/patología , Estudios Retrospectivos , Sensibilidad y Especificidad , Cirugía Asistida por Computador/métodos , Resultado del Tratamiento , Vitrectomía/métodosRESUMEN
Light toxicity is suspected to enhance certain retinal degenerative processes such as age-related macular degeneration. Death of photoreceptors can be induced by their exposure to the visible light, and although cellular processes within photoreceptors have been characterized extensively, the role of the retinal pigment epithelium (RPE) in this model is less well understood. We demonstrate that exposition to intense light causes the immediate breakdown of the outer blood-retinal barrier (BRB). In a molecular level, we observed the slackening of adherens junctions tying up the RPE and massive leakage of albumin into the neural retina. Retinal pigment epithelial cells normally secrete vascular endothelial growth factor (VEGF) at their basolateral side; light damage in contrast leads to VEGF increase on the apical side--that is, in the neuroretina. Blocking VEGF, by means of lentiviral gene transfer to express an anti-VEGF antibody in RPE cells, inhibits outer BRB breakdown and retinal degeneration, as illustrated by functional, behavioral and morphometric analysis. Our data show that exposure to high levels of visible light induces hyperpermeability of the RPE, likely involving VEGF signaling. The resulting retinal edema contributes to irreversible damage to photoreceptors. These data suggest that anti-VEGF compounds are of therapeutic interest when the outer BRB is altered by retinal stresses.
Asunto(s)
Luz , Células Fotorreceptoras de Vertebrados/patología , Epitelio Pigmentado de la Retina/patología , Epitelio Pigmentado de la Retina/efectos de la radiación , Factor A de Crecimiento Endotelial Vascular/metabolismo , Albúminas/metabolismo , Animales , Muerte Celular/efectos de los fármacos , Muerte Celular/efectos de la radiación , Modelos Animales de Enfermedad , Ratones , Ratones Endogámicos BALB C , Fármacos Neuroprotectores/farmacología , Permeabilidad/efectos de los fármacos , Permeabilidad/efectos de la radiación , Células Fotorreceptoras de Vertebrados/efectos de los fármacos , Células Fotorreceptoras de Vertebrados/metabolismo , Células Fotorreceptoras de Vertebrados/efectos de la radiación , Epitelio Pigmentado de la Retina/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Transducción de Señal/efectos de la radiación , Factor A de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Receptor 2 de Factores de Crecimiento Endotelial Vascular/metabolismo , Familia-src Quinasas/metabolismoAsunto(s)
Aspirina/uso terapéutico , Ácido Fólico/uso terapéutico , Fotocoagulación/métodos , Oclusión de la Vena Retiniana/diagnóstico , Oclusión de la Vena Retiniana/terapia , Trastornos de la Visión/prevención & control , Antiinflamatorios no Esteroideos/uso terapéutico , Terapia Combinada/métodos , Humanos , Masculino , Persona de Mediana Edad , Oclusión de la Vena Retiniana/complicaciones , Resultado del Tratamiento , Trastornos de la Visión/diagnóstico , Trastornos de la Visión/etiologíaAsunto(s)
Antivirales/efectos adversos , Ganciclovir/análogos & derivados , Uveítis/inducido químicamente , Uveítis/prevención & control , Anciano , Antivirales/uso terapéutico , Retinitis por Citomegalovirus/complicaciones , Retinitis por Citomegalovirus/tratamiento farmacológico , Femenino , Ganciclovir/efectos adversos , Ganciclovir/uso terapéutico , Humanos , Leucemia Linfocítica Crónica de Células B/complicaciones , Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , ValganciclovirRESUMEN
PURPOSE: To correlate patellar reflex inhibition with sympathetic knee joint effusion. METHODS: 65 women and 40 men aged 45 to 75 (mean, 65) years underwent hip surgery. The surgery entailed dynamic hip screw fixation using the lateral approach with reflection of the vastus lateralis for pertrochantric fractures (n = 49), and hip hemiarthroplasty or total hip replacement using the Watson-Jones approach (n = 38) or hip hemiarthroplasty using the posterior approach (n = 18) for subcapital femoral fractures (n = 28) or osteoarthritis (n = 28). Knee joint effusion, patellar reflex, and thigh circumference were assessed in both legs before and after surgery (at day 0.5, 2, 7, 14, 30, and 45). Time-sequence plots were used for chronological analysis, and correlation between patellar reflex inhibition and knee joint effusion was tested. RESULTS: In the time-sequence plot, the peak frequency of patellar reflex inhibition (on day 0.5) preceded that of the knee joint effusion and the thigh circumference increase (on day 2). Patellar reflex inhibition correlated positively with the knee joint effusion (r = 0.843, p = 0.035). These 2 factors correlated significantly for all 3 surgical approaches (p < 0.0005). All 3 approaches were associated with patellar reflex inhibition on day 0.5 (p = 0.033) and knee joint effusion on day 2 (p = 0.051). CONCLUSION: Surgical trauma of the thigh may cause patellar reflex inhibition and subsequently knee joint effusion.
Asunto(s)
Artroplastia de Reemplazo de Cadera , Fracturas de Cadera/cirugía , Hidrartrosis/etiología , Articulación de la Rodilla , Osteoartritis de la Cadera/cirugía , Complicaciones Posoperatorias , Anciano , Estudios de Cohortes , Femenino , Fracturas de Cadera/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Osteoartritis de la Cadera/complicaciones , Ligamento Rotuliano , Reflejo Anormal , Estudios Retrospectivos , Factores de TiempoRESUMEN
BACKGROUND: Intraocular gas bubbles expand as patients move up to higher altitude. This may cause an acute intraocular pressure (IOP) rise with associated vascular obstructions and visual loss. MATERIALS AND METHODS: Two pseudophakic patients underwent a pars plana vitrectomy and 23% SF6 gas tamponade for a pseudophakic retinal detachment. During the immediate post-operative phase, the patients travelled daily up to their domicile, which was situated approximately 600 m higher than the level where they had been operated on. These travels were always without any pain or visual loss. However 1 week after surgery both patients developed severe ocular pain, and one patient had complete temporary loss of vision after ascending to altitude levels, which had previously presented no problem. Both episodes occurred in parallel with a change in barometric pressure. RESULTS: Treatment with acetazolamide reduced the increased IOP to normal levels, and visual acuity recovered. CONCLUSIONS: Although the post-operative size of an intraocular gas bubble decreases progressively over time, problems with bubble expansion may still occur even at a late stage if meteorological factors, that may increase the bubble size, change.
Asunto(s)
Altitud , Fluorocarburos/efectos adversos , Gases , Hipertensión Ocular/diagnóstico , Hipertensión Ocular/etiología , Humanos , Hipertensión Ocular/prevención & control , Factores de RiesgoAsunto(s)
Isquemia/complicaciones , Isquemia/diagnóstico , Oclusión de la Arteria Retiniana/complicaciones , Oclusión de la Arteria Retiniana/diagnóstico , Oclusión de la Vena Retiniana/complicaciones , Oclusión de la Vena Retiniana/diagnóstico , Vasos Retinianos , Humanos , Isquemia/terapia , Masculino , Persona de Mediana Edad , Oclusión de la Arteria Retiniana/terapia , Oclusión de la Vena Retiniana/terapia , SíndromeAsunto(s)
Neoplasias de la Coroides/patología , Angiografía con Fluoresceína/métodos , Verde de Indocianina , Leucemia-Linfoma Linfoblástico de Células Precursoras B/patología , Neoplasias de la Retina/patología , Retinoscopía/métodos , Coriorretinopatía Serosa Central/patología , Femenino , Humanos , Persona de Mediana EdadRESUMEN
PURPOSE: To assess the safety and efficacy of treatment of macular edema secondary to central retinal vein occlusion (CRVO) with intravitreal bevacizumab. PATIENTS AND METHOD: The ongoing prospective study included 8 consecutive patients (8 eyes) with macular edema secondary to CRVO (6 non ischemic and 2 ischemic), treated with intravitreal injection of 1.25 mg (0.05 mL) of bevacizumab. Main outcome was best corrected visual acuity (BCVA) and central foveal thickness (CFT) measured by optical coherence tomography monthly during one year. Retreatment criteria include decrease of BCVA, persistence of macular edema on angiograms and increase of CFT. RESULTS: Mean age of the eight patients was 68 years (range: 50-82 years). Mean duration of symptoms before injection was 98 days (range: 3-289). Mean follow-up was 3.25 months. At baseline, mean BCVA was 0.84 logMar and mean baseline CFT was 771 microm. Mean BCVA was 0.36 and mean CFT thickness was 275 microm (n = 8) at month 1, 0.41 and 411 microm at month 2 (n = 7), 0.3 and 344 microm at month 3 (n = 6), 0.3 and 397 microm at month 4 (n = 5), respectively. In 75 % of patients, a single injection was not sufficient, and retreatment needed. No serious adverse events were observed. CONCLUSIONS: Treatment of macular edema secondary to CRVO with intravitreal bevacizumab injection of 1.25 mg was well tolerated and associated with marked macular thickness reduction and BCVA improvement in all patients. A trend towards reduction of foveal thickness and improvement of visual acuity was observed in both acute and chronic CRVO.
Asunto(s)
Anticuerpos Monoclonales/administración & dosificación , Edema Macular/tratamiento farmacológico , Edema Macular/etiología , Oclusión de la Vena Retiniana/complicaciones , Oclusión de la Vena Retiniana/tratamiento farmacológico , Anciano , Anciano de 80 o más Años , Inhibidores de la Angiogénesis/administración & dosificación , Anticuerpos Monoclonales Humanizados , Bevacizumab , Femenino , Humanos , Edema Macular/diagnóstico , Masculino , Persona de Mediana Edad , Oclusión de la Vena Retiniana/diagnóstico , Resultado del TratamientoRESUMEN
BACKGROUND: The aim of this communication is to describe an unusual and serious complication of retrobulbar anaesthesia for cataract surgery. HISTORY AND SIGNS: A 78-year-old female was referred for visual loss (light perception) 24 hours after apparently uneventful cataract surgery with retrobulbar anaesthesia in her left eye. Fundus examination revealed multiple arterial emboli and a localised retinal detachment. MRI revealed a retrobulbar hypersignal of the optic nerve associated with perineuritis. The cardiovascular examination was normal. We assumed this condition resulted from injection of the anaesthetic mixture into the optic nerve. THERAPY AND OUTCOME: In order to improve retinal circulation and oxygenation, the intraocular pressure was maximally lowered and anticalcic therapy administered, expecting optimal arterial dilatation. Methylprednisolone (1 g/day 3 days i. v., then rapidly tapered) was also added. The retina slowly reattached but visual acuity remained unchanged. CONCLUSIONS: Retrobulbar anaesthesia is routinely used for ocular surgery. Serious complications may still happen, however. This case adds to the previously reported spectrum of complications from retrobulbar anaesthesia.